The fund seeks investment results that correspond to 2x the daily performance of its underlying index, which represents a market-cap-weighted basket of North American companies with significant businesses in the cannabis industry. These companies are deemed to be producer and/or supplier of cannabis, a biotech company engaged in research and development of cannabinoids, or a company that focuses its investments on the cannabis sector. As a levered fund, it is not a buy-and-hold investment and should not be expected to provide index leverage returns greater than a one-day period.